Comerica Bank’s Opus Genetics IRD Stock Holding History

Comerica Bank’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$24.1K	Hold	12,000	–	–	﹤0.01%	3048
2025 Q3	$19.8K	Hold	12,000	–	–	﹤0.01%	3095
2025 Q2	$11.3K	Sell	12,000 -18,000	-60%	-$16.7K	﹤0.01%	3183
2025 Q1	$29.5K	Hold	30,000	–	–	﹤0.01%	2938
2024 Q4	$35.7K	Hold	30,000	–	–	﹤0.01%	2894
2024 Q3	$39.3K	Hold	30,000	–	–	﹤0.01%	2855
2024 Q2	$45.9K	Hold	30,000	–	–	﹤0.01%	2776
2024 Q1	$60.3K	Hold	30,000	–	–	﹤0.01%	2706
2023 Q4	$90.3K	Hold	30,000	–	–	﹤0.01%	2531
2023 Q3	$101K	Buy	+30,000	New	+$120K	﹤0.01%	2473
2022 Q4	$110K	Hold	30,000	–	–	﹤0.01%	2102
2022 Q3	$68K	Hold	30,000	–	–	﹤0.01%	2102
2022 Q2	$58K	Hold	30,000	–	–	﹤0.01%	2136
2022 Q1	$82K	Hold	30,000	–	–	﹤0.01%	2141
2021 Q4	$90K	Hold	30,000	–	–	﹤0.01%	2132
2021 Q3	$127K	Hold	30,000	–	–	﹤0.01%	2174
2021 Q2	$124K	Hold	30,000	–	–	﹤0.01%	2291
2021 Q1	$143K	Hold	30,000	–	–	﹤0.01%	2281
2020 Q4	$322K	Buy	+30,000	New	+$207K	﹤0.01%	2108

Other funds holding IRD

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BCM

BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

MBAM

Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Comerica Bank's IRD Position: Q4 2025 in Review

Comerica Bank held its Opus Genetics (IRD) position steady in Q4 2025 at 12,000 shares worth $24.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3048.

Comerica Bank first reported a position in IRD in Q4 2020 and has held it in 19 quarters since. The position peaked at $322K in Q4 2020. 59 funds tracked by Wall St. Rank hold IRD as of Q4 2025.

Comerica Bank held 12,000 shares of Opus Genetics worth $24.1K as of Q4 2025.
Comerica Bank left its Opus Genetics share count unchanged in Q4 2025.
Opus Genetics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3048 holding.
Comerica Bank first reported a position in Opus Genetics in Q4 2020 and has held it in 19 quarters since.
Comerica Bank's Opus Genetics position peaked at $322K in Q4 2020.
59 funds tracked by Wall St. Rank held Opus Genetics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.